During obesity and aging, a raise in the activity of aromatase enzyme converts testosterone into estrogens in men, further reducing circulating plasma levels and the ability of testosterone to exert its appropriate metabolic actions (40, 69). Here, CYP19A1 is linked to obesity disorder.